Richard J Pietras

Title(s)Professor-in-Residence, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Development of New Therapeutics for Pancreatic Cancer Management
    NIH R21CA176337Jun 1, 2013 - Mar 31, 2016
    Role: Principal Investigator
    (2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
    NIH U54CA143930Sep 29, 2009 - Aug 31, 2021
    Role: Principal Investigator
    NEW ENDOCRINE THERAPY IN OLDER WOMEN WITH BREAST CANCER
    NIH R01AG014785Aug 15, 1997 - Jun 30, 2001
    Role: Principal Investigator
    GROWTH FACTOR RECEPTOR DIRECTED THERAPY IN CANCER
    NIH R29CA060835Feb 1, 1995 - Jan 31, 2000
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC. JTO Clin Res Rep. 2021 Apr; 2(4):100150. Young PA, Márquez-Garbán DC, Noor ZS, Moatamed N, Elashoff D, Grogan T, Romero T, Sasano H, Saito R, Rausch R, Hamilton N, Dubinett SM, Garon EB, Pietras RJ. PMID: 34590007; PMCID: PMC8474426.
      View in: PubMed   Mentions:
    2. Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice. J Cancer Res Ther Oncol. 2020; 8(1). Su F, Gm A, Palgunachari MN, White CR, Stessman H, Wu Y, Vadgama J, Pietras R, Nguyen D, Reddy ST, Farias-Eisner R. PMID: 32462055.
      View in: PubMed   Mentions:
    3. Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy. J Steroid Biochem Mol Biol. 2019 10; 193:105415. Márquez-Garbán DC, Deng G, Comin-Anduix B, Garcia AJ, Xing Y, Chen HW, Cheung-Lau G, Hamilton N, Jung ME, Pietras RJ. PMID: 31226312.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    4. Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression. Cancer Lett. 2019 05 01; 449:66-75. Márquez-Garbán DC, Gorrín-Rivas M, Chen HW, Sterling C, Elashoff D, Hamilton N, Pietras RJ. PMID: 30771431.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    5. Aromatase inhibitors combined with aspirin to prevent lung cancer in preclinical models. Transl Lung Cancer Res. 2018 Dec; 7(Suppl 4):S373-S376. Young PA, Pietras RJ. PMID: 30705860.
      View in: PubMed   Mentions:
    6. Estrogen receptor-beta is a potential target for triple negative breast cancer treatment. Oncotarget. 2018 Sep 21; 9(74):33912-33930. Austin D, Hamilton N, Elshimali Y, Pietras R, Wu Y, Vadgama J. PMID: 30338035.
      View in: PubMed   Mentions: 11     Fields:    
    7. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer. 2018 09; 123:91-98. Garon EB, Siegfried JM, Stabile LP, Young PA, Marquez-Garban DC, Park DJ, Patel R, Hu EH, Sadeghi S, Parikh RJ, Reckamp KL, Adams B, Elashoff RM, Elashoff D, Grogan T, Wang HJ, Dacic S, Brennan M, Valdes Y, Davenport S, Dubinett SM, Press MF, Slamon DJ, Pietras RJ. PMID: 30089602.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    8. Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol. 2018 05 05; 466:51-72. Boonyaratanakornkit V, Hamilton N, Márquez-Garbán DC, Pateetin P, McGowan EM, Pietras RJ. PMID: 29146555.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    9. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int J Mol Sci. 2017 Nov 02; 18(11). Hamilton N, Austin D, Márquez-Garbán D, Sanchez R, Chau B, Foos K, Wu Y, Vadgama J, Pietras R. PMID: 29099049.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer. Oncotarget. 2017 Jun 13; 8(24):38294-38308. Deng X, Apple S, Zhao H, Song J, Lee M, Luo W, Wu X, Chung D, Pietras RJ, Chang HR. PMID: 28418843.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    11. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat. 2017 Jun; 163(3):449-460. Wu Y, Tran T, Dwabe S, Sarkissyan M, Kim J, Nava M, Clayton S, Pietras R, Farias-Eisner R, Vadgama JV. PMID: 28337662.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    12. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells. Cancer Lett. 2016 May 01; 374(2):279-91. Kawprasertsri S, Pietras RJ, Marquez-Garban DC, Boonyaratanakornkit V. PMID: 26892043.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    13. Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking status. PLoS One. 2015; 10(5):e0127600. Mah V, Alavi M, Márquez-Garbán DC, Maresh EL, Kim SR, Horvath S, Bagryanova L, Huerta-Yepez S, Chia D, Pietras R, Goodglick L. PMID: 26001082.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    14. Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer. Biomed Res Int. 2015; 2015:925703. Hamilton N, Márquez-Garbán D, Mah V, Fernando G, Elshimali Y, Garbán H, Elashoff D, Vadgama J, Goodglick L, Pietras R. PMID: 25874233.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    15. Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer. Crit Rev Oncog. 2015; 20(5-6):373-90. Hamilton N, Marquez-Garban D, Mah VH, Elshimali Y, Elashoff D, Garon EB, Vadgama J, Pietras R. PMID: 27279236.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):270-8. Garon EB, Pietras RJ, Finn RS, Kamranpour N, Pitts S, Márquez-Garbán DC, Desai AJ, Dering J, Hosmer W, von Euw EM, Dubinett SM, Slamon DJ. PMID: 23399957.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    17. The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer. Lung Cancer Manag. 2012 Dec; 1(4):259-272. Kazmi N, Márquez-Garbán DC, Aivazyan L, Hamilton N, Garon EB, Goodglick L, Pietras RJ. PMID: 23650476.
      View in: PubMed   Mentions:
    18. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids. 2011 Aug; 76(9):910-20. Marquez-Garban DC, Mah V, Alavi M, Maresh EL, Chen HW, Bagryanova L, Horvath S, Chia D, Garon E, Goodglick L, Pietras RJ. PMID: 21600232.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    19. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer. 2011 Nov; 74(2):318-25. Mah V, Marquez D, Alavi M, Maresh EL, Zhang L, Yoon N, Horvath S, Bagryanova L, Fishbein MC, Chia D, Pietras R, Goodglick L. PMID: 21511357.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    20. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Ann N Y Acad Sci. 2009 Feb; 1155:194-205. Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ. PMID: 19250205.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    21. Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions. Cancer. 2008 Nov 01; 113(9):2385-97. Hurvitz SA, Pietras RJ. PMID: 18819158.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    22. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res. 2007 Nov 01; 67(21):10484-90. Mah V, Seligson DB, Li A, Márquez DC, Wistuba II, Elshimali Y, Fishbein MC, Chia D, Pietras RJ, Goodglick L. PMID: 17974992.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimals
    23. Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res. 2007 Aug 15; 13(16):4672-6. Pietras RJ, Márquez-Garbán DC. PMID: 17699844.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    24. Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Res Treat. 2008 Apr; 108(3):351-61. Levin ER, Pietras RJ. PMID: 17592774.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    25. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids. 2007 Feb; 72(2):135-43. Márquez-Garbán DC, Chen HW, Fishbein MC, Goodglick L, Pietras RJ. PMID: 17276470.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansAnimalsCells
    26. Biologic basis of sequential and combination therapies for hormone-responsive breast cancer. Oncologist. 2006 Jul-Aug; 11(7):704-17. Pietras RJ. PMID: 16880230.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    27. The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis. 2006 Dec; 27(12):2424-33. Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour G, Zhang L, Lu M, Weinberg O, Rao JY, Brooks MN. PMID: 16785249.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    28. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol. 2006 Feb 26; 246(1-2):91-100. Márquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. PMID: 16388889.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    29. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol. 2006 Jan-Feb; 8(1):36-42. Pio BS, Park CK, Pietras R, Hsueh WA, Satyamurthy N, Pegram MD, Czernin J, Phelps ME, Silverman DH. PMID: 16362149.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    30. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005 Dec 15; 65(24):11287-91. Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ. PMID: 16357134.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimals
    31. Estrogen receptors and cell signaling. Science. 2005 Oct 07; 310(5745):51-3; author reply 51-3. Pietras RJ, Levin ER, Szego CM. PMID: 16210518.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    32. New approaches to reverse resistance to hormonal therapy in human breast cancer. Drug Resist Updat. 2005 Aug; 8(4):219-33. Weinberg OK, Marquez-Garban DC, Pietras RJ. PMID: 16054421.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    33. Overview of the FASEB 2004 summer research conference on steroid hormone receptors: integration of plasma membrane and nuclear-initiated signaling in hormone action. Steroids. 2005 May-Jun; 70(5-7):345-6. Pietras RJ. PMID: 15862815.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    34. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids. 2005 May-Jun; 70(5-7):372-81. Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M. PMID: 15862820.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    35. Targeted therapy: wave of the future. J Clin Oncol. 2005 Mar 10; 23(8):1776-81. Pegram MD, Pietras R, Bajamonde A, Klein P, Fyfe G. PMID: 15755985.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    36. Antiangiogenic Steroids in Human Cancer Therapy. Evid Based Complement Alternat Med. 2005 03; 2(1):49-57. Pietras RJ, Weinberg OK. PMID: 15841278.
      View in: PubMed   Mentions:
    37. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc Natl Acad Sci U S A. 2005 Feb 15; 102(7):2632-6. Garbán HJ, Márquez-Garbán DC, Pietras RJ, Ignarro LJ. PMID: 15699347.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    38. Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance. Breast Cancer Res Treat. 2005; 93 Suppl 1:S11-8. Dowsett M, Nicholson RI, Pietras RJ. PMID: 16247595.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    39. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer. J Natl Cancer Inst. 2004 May 19; 96(10):739-49. Pegram MD, Konecny GE, O'Callaghan C, Beryt M, Pietras R, Slamon DJ. PMID: 15150302.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansAnimalsCells
    40. Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature. Breast J. 2003 Sep-Oct; 9(5):361-73. Pietras RJ. PMID: 12968955.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    41. Membrane receptors for steroid hormones: signal transduction and physiological significance. J Cell Biochem. 2003 Feb 15; 88(3):438-45. Nemere I, Pietras RJ, Blackmore PF. PMID: 12532320.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    42. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene. 2002 Apr 25; 21(18):2805-14. Li D, Williams JI, Pietras RJ. PMID: 11973639.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    43. Steroid hormone receptors in target cell membranes. Endocrine. 2001 Apr; 14(3):417-27. Pietras RJ, Nemere I, Szego CM. PMID: 11444440.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    Richard's Networks
    Concepts (214)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (21)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-866-g4098221c on PROFILES-PWEB02.

    Copyright © The Regents of the University of California